JP5857008B2 - Ｃ−４”位置換マクロライド誘導体を含有する医薬 - Google Patents

Ｃ−４”位置換マクロライド誘導体を含有する医薬 Download PDF

Info

Publication number
JP5857008B2
JP5857008B2 JP2013169941A JP2013169941A JP5857008B2 JP 5857008 B2 JP5857008 B2 JP 5857008B2 JP 2013169941 A JP2013169941 A JP 2013169941A JP 2013169941 A JP2013169941 A JP 2013169941A JP 5857008 B2 JP5857008 B2 JP 5857008B2
Authority
JP
Japan
Prior art keywords
group
compound
formula
reference example
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013169941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014058509A (ja
JP2014058509A5 (enExample
Inventor
杉本　智洋
智洋 杉本
直樹 笹本
直樹 笹本
淳 黒坂
淳 黒坂
真知 林
真知 林
加奈子 山本
加奈子 山本
樫村　政人
政人 樫村
康信 宇敷
康信 宇敷
荻田　晴久
晴久 荻田
知明 三浦
知明 三浦
憲一 兼本
憲一 兼本
興 久村
興 久村
諭 吉田
諭 吉田
圭司 田村
圭司 田村
設楽　永紀
永紀 設楽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP2013169941A priority Critical patent/JP5857008B2/ja
Publication of JP2014058509A publication Critical patent/JP2014058509A/ja
Publication of JP2014058509A5 publication Critical patent/JP2014058509A5/ja
Application granted granted Critical
Publication of JP5857008B2 publication Critical patent/JP5857008B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2013169941A 2012-08-20 2013-08-19 Ｃ−４”位置換マクロライド誘導体を含有する医薬 Expired - Fee Related JP5857008B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013169941A JP5857008B2 (ja) 2012-08-20 2013-08-19 Ｃ−４”位置換マクロライド誘導体を含有する医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012181339 2012-08-20
JP2012181339 2012-08-20
JP2013169941A JP5857008B2 (ja) 2012-08-20 2013-08-19 Ｃ−４”位置換マクロライド誘導体を含有する医薬

Publications (3)

Publication Number Publication Date
JP2014058509A JP2014058509A (ja) 2014-04-03
JP2014058509A5 JP2014058509A5 (enExample) 2014-07-17
JP5857008B2 true JP5857008B2 (ja) 2016-02-10

Family

ID=50615337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013169941A Expired - Fee Related JP5857008B2 (ja) 2012-08-20 2013-08-19 Ｃ−４”位置換マクロライド誘導体を含有する医薬

Country Status (1)

Country Link
JP (1) JP5857008B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR102810A1 (es) * 2014-08-18 2017-03-29 Taisho Pharmaceutical Co Ltd Derivado de macrólido sustituido en la posición c-4
CN104592057B (zh) * 2015-01-12 2017-05-10 中国科学院上海有机化学研究所 一种三硝基乙基氨基甲酸酯的合成方法
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 Ｃ－４"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN106748905B (zh) * 2016-12-14 2018-04-13 河南省化工研究所有限责任公司 一种制备2‑氨基乙基磺酰胺盐酸盐的方法
CN106928294A (zh) * 2017-03-22 2017-07-07 上海启雁实业有限公司 制备酮内酯大环内酯类抗生素的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2242983T3 (es) * 1996-09-04 2005-11-16 Abbott Laboratories Cetolidos 6-0-sustituidos que tienen una actividad antibacteriana.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
WO2008143729A2 (en) * 2007-02-28 2008-11-27 Rib-X Pharmaceuticals, Inc. Macrolide compounds and methods of making and using the same
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4

Also Published As

Publication number Publication date
JP2014058509A (ja) 2014-04-03

Similar Documents

Publication Publication Date Title
JP5687777B2 (ja) Ｃ−４”位置換マクロライド誘導体
RU2455308C2 (ru) Макролидные производные
JP5857008B2 (ja) Ｃ−４”位置換マクロライド誘導体を含有する医薬
HUP0002209A2 (hu) 4-Szubsztituált-9-dezoxo-9A-aza-9A-homoeritromicin-származékok és e vegyületeket tartalmazó gyógyászati készítmények
JPWO2007091393A1 (ja) １０ａ−アザライド化合物
US8299035B2 (en) 10a-azalide compound having 4-membered ring structure
JP7112963B2 (ja) セコマクロライド化合物
CN113573779A (zh) C10-亚烷基取代的13元大环内酯及其用途
JP2014058507A (ja) １１位アミノ置換マクロライド誘導体
HK1191338A (en) C-4"position substituted macrolide derivative
HK1191338B (en) C-4"position substituted macrolide derivative
JP2014058508A (ja) ９位オキシム置換マクロライド誘導体
HK40063248A (en) C10-alkylene substituted 13-membered macrolides and uses thereof
HK1133037B (en) Macrolide derivative

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140529

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A132

Effective date: 20150512

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150707

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151208

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151214

R150 Certificate of patent or registration of utility model

Ref document number: 5857008

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees